Global Obesity Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Obesity Treatment Industry Forecast” looks at past sales and reviews total world Obesity Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Obesity Treatment sales for 2023 through 2029. With Obesity Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Obesity Treatment industry.
This Insight Report provides a comprehensive analysis of the global Obesity Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Obesity Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Obesity Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Obesity Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Obesity Treatment.
The global Obesity Treatment market size is projected to grow from US$ 5333.5 million in 2022 to US$ 13260 million in 2029; it is expected to grow at a CAGR of 13.9% from 2023 to 2029.
United States market for Obesity Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Obesity Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Obesity Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Obesity Treatment players cover NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Medtronic (U.S.), F. Hoffmann-La Roche (Switzerland), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.) and Apollo Endosurgery (U.S.), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Obesity Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Obesity Treatment Industry Forecast” looks at past sales and reviews total world Obesity Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Obesity Treatment sales for 2023 through 2029. With Obesity Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Obesity Treatment industry.
This Insight Report provides a comprehensive analysis of the global Obesity Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Obesity Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Obesity Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Obesity Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Obesity Treatment.
The global Obesity Treatment market size is projected to grow from US$ 5333.5 million in 2022 to US$ 13260 million in 2029; it is expected to grow at a CAGR of 13.9% from 2023 to 2029.
United States market for Obesity Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Obesity Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Obesity Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Obesity Treatment players cover NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Medtronic (U.S.), F. Hoffmann-La Roche (Switzerland), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.) and Apollo Endosurgery (U.S.), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Obesity Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Surgical & Implant Devices
- Medication Therapy
- Dietary
- Other
- Children
- Adults
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NutriSystem, Inc. (U.S.)
- Kellogg Company (U.S.)
- Ethicon, Inc. (U.S.)
- Medtronic (U.S.)
- F. Hoffmann-La Roche (Switzerland)
- Atkins Nutritionals, Inc. (U.S.)
- Herbalife Ltd. (U.S.)
- Covidien plc (U.S.)
- Apollo Endosurgery (U.S.)
- Amer Sports (Finland)
- Johnson Health Technology, Ltd. (Taiwan)
- Cybex International (U.S.)
- USGI Medical (U.S.)
- Olympus Corporation (Japan)
- Brunswick Corporation (U.S.)
- Technogym SpA (Italy)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Obesity Treatment Market Size 2018-2029
2.1.2 Obesity Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Obesity Treatment Segment by Type
2.2.1 Surgical & Implant Devices
2.2.2 Medication Therapy
2.2.3 Dietary
2.2.4 Other
2.3 Obesity Treatment Market Size by Type
2.3.1 Obesity Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Obesity Treatment Market Size Market Share by Type (2018-2023)
2.4 Obesity Treatment Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Obesity Treatment Market Size by Application
2.5.1 Obesity Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Obesity Treatment Market Size Market Share by Application (2018-2023)
3 OBESITY TREATMENT MARKET SIZE BY PLAYER
3.1 Obesity Treatment Market Size Market Share by Players
3.1.1 Global Obesity Treatment Revenue by Players (2018-2023)
3.1.2 Global Obesity Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Obesity Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OBESITY TREATMENT BY REGIONS
4.1 Obesity Treatment Market Size by Regions (2018-2023)
4.2 Americas Obesity Treatment Market Size Growth (2018-2023)
4.3 APAC Obesity Treatment Market Size Growth (2018-2023)
4.4 Europe Obesity Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Obesity Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Obesity Treatment Market Size by Country (2018-2023)
5.2 Americas Obesity Treatment Market Size by Type (2018-2023)
5.3 Americas Obesity Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Obesity Treatment Market Size by Region (2018-2023)
6.2 APAC Obesity Treatment Market Size by Type (2018-2023)
6.3 APAC Obesity Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Obesity Treatment by Country (2018-2023)
7.2 Europe Obesity Treatment Market Size by Type (2018-2023)
7.3 Europe Obesity Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Obesity Treatment by Region (2018-2023)
8.2 Middle East & Africa Obesity Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Obesity Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OBESITY TREATMENT MARKET FORECAST
10.1 Global Obesity Treatment Forecast by Regions (2024-2029)
10.1.1 Global Obesity Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Obesity Treatment Forecast
10.1.3 APAC Obesity Treatment Forecast
10.1.4 Europe Obesity Treatment Forecast
10.1.5 Middle East & Africa Obesity Treatment Forecast
10.2 Americas Obesity Treatment Forecast by Country (2024-2029)
10.2.1 United States Obesity Treatment Market Forecast
10.2.2 Canada Obesity Treatment Market Forecast
10.2.3 Mexico Obesity Treatment Market Forecast
10.2.4 Brazil Obesity Treatment Market Forecast
10.3 APAC Obesity Treatment Forecast by Region (2024-2029)
10.3.1 China Obesity Treatment Market Forecast
10.3.2 Japan Obesity Treatment Market Forecast
10.3.3 Korea Obesity Treatment Market Forecast
10.3.4 Southeast Asia Obesity Treatment Market Forecast
10.3.5 India Obesity Treatment Market Forecast
10.3.6 Australia Obesity Treatment Market Forecast
10.4 Europe Obesity Treatment Forecast by Country (2024-2029)
10.4.1 Germany Obesity Treatment Market Forecast
10.4.2 France Obesity Treatment Market Forecast
10.4.3 UK Obesity Treatment Market Forecast
10.4.4 Italy Obesity Treatment Market Forecast
10.4.5 Russia Obesity Treatment Market Forecast
10.5 Middle East & Africa Obesity Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Obesity Treatment Market Forecast
10.5.2 South Africa Obesity Treatment Market Forecast
10.5.3 Israel Obesity Treatment Market Forecast
10.5.4 Turkey Obesity Treatment Market Forecast
10.5.5 GCC Countries Obesity Treatment Market Forecast
10.6 Global Obesity Treatment Forecast by Type (2024-2029)
10.7 Global Obesity Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 NutriSystem, Inc. (U.S.)
11.1.1 NutriSystem, Inc. (U.S.) Company Information
11.1.2 NutriSystem, Inc. (U.S.) Obesity Treatment Product Offered
11.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 NutriSystem, Inc. (U.S.) Main Business Overview
11.1.5 NutriSystem, Inc. (U.S.) Latest Developments
11.2 Kellogg Company (U.S.)
11.2.1 Kellogg Company (U.S.) Company Information
11.2.2 Kellogg Company (U.S.) Obesity Treatment Product Offered
11.2.3 Kellogg Company (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Kellogg Company (U.S.) Main Business Overview
11.2.5 Kellogg Company (U.S.) Latest Developments
11.3 Ethicon, Inc. (U.S.)
11.3.1 Ethicon, Inc. (U.S.) Company Information
11.3.2 Ethicon, Inc. (U.S.) Obesity Treatment Product Offered
11.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Ethicon, Inc. (U.S.) Main Business Overview
11.3.5 Ethicon, Inc. (U.S.) Latest Developments
11.4 Medtronic (U.S.)
11.4.1 Medtronic (U.S.) Company Information
11.4.2 Medtronic (U.S.) Obesity Treatment Product Offered
11.4.3 Medtronic (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Medtronic (U.S.) Main Business Overview
11.4.5 Medtronic (U.S.) Latest Developments
11.5 F. Hoffmann-La Roche (Switzerland)
11.5.1 F. Hoffmann-La Roche (Switzerland) Company Information
11.5.2 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Offered
11.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 F. Hoffmann-La Roche (Switzerland) Main Business Overview
11.5.5 F. Hoffmann-La Roche (Switzerland) Latest Developments
11.6 Atkins Nutritionals, Inc. (U.S.)
11.6.1 Atkins Nutritionals, Inc. (U.S.) Company Information
11.6.2 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product Offered
11.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Atkins Nutritionals, Inc. (U.S.) Main Business Overview
11.6.5 Atkins Nutritionals, Inc. (U.S.) Latest Developments
11.7 Herbalife Ltd. (U.S.)
11.7.1 Herbalife Ltd. (U.S.) Company Information
11.7.2 Herbalife Ltd. (U.S.) Obesity Treatment Product Offered
11.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Herbalife Ltd. (U.S.) Main Business Overview
11.7.5 Herbalife Ltd. (U.S.) Latest Developments
11.8 Covidien plc (U.S.)
11.8.1 Covidien plc (U.S.) Company Information
11.8.2 Covidien plc (U.S.) Obesity Treatment Product Offered
11.8.3 Covidien plc (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Covidien plc (U.S.) Main Business Overview
11.8.5 Covidien plc (U.S.) Latest Developments
11.9 Apollo Endosurgery (U.S.)
11.9.1 Apollo Endosurgery (U.S.) Company Information
11.9.2 Apollo Endosurgery (U.S.) Obesity Treatment Product Offered
11.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Apollo Endosurgery (U.S.) Main Business Overview
11.9.5 Apollo Endosurgery (U.S.) Latest Developments
11.10 Amer Sports (Finland)
11.10.1 Amer Sports (Finland) Company Information
11.10.2 Amer Sports (Finland) Obesity Treatment Product Offered
11.10.3 Amer Sports (Finland) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Amer Sports (Finland) Main Business Overview
11.10.5 Amer Sports (Finland) Latest Developments
11.11 Johnson Health Technology, Ltd. (Taiwan)
11.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Information
11.11.2 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product Offered
11.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Johnson Health Technology, Ltd. (Taiwan) Main Business Overview
11.11.5 Johnson Health Technology, Ltd. (Taiwan) Latest Developments
11.12 Cybex International (U.S.)
11.12.1 Cybex International (U.S.) Company Information
11.12.2 Cybex International (U.S.) Obesity Treatment Product Offered
11.12.3 Cybex International (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Cybex International (U.S.) Main Business Overview
11.12.5 Cybex International (U.S.) Latest Developments
11.13 USGI Medical (U.S.)
11.13.1 USGI Medical (U.S.) Company Information
11.13.2 USGI Medical (U.S.) Obesity Treatment Product Offered
11.13.3 USGI Medical (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 USGI Medical (U.S.) Main Business Overview
11.13.5 USGI Medical (U.S.) Latest Developments
11.14 Olympus Corporation (Japan)
11.14.1 Olympus Corporation (Japan) Company Information
11.14.2 Olympus Corporation (Japan) Obesity Treatment Product Offered
11.14.3 Olympus Corporation (Japan) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Olympus Corporation (Japan) Main Business Overview
11.14.5 Olympus Corporation (Japan) Latest Developments
11.15 Brunswick Corporation (U.S.)
11.15.1 Brunswick Corporation (U.S.) Company Information
11.15.2 Brunswick Corporation (U.S.) Obesity Treatment Product Offered
11.15.3 Brunswick Corporation (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Brunswick Corporation (U.S.) Main Business Overview
11.15.5 Brunswick Corporation (U.S.) Latest Developments
11.16 Technogym SpA (Italy)
11.16.1 Technogym SpA (Italy) Company Information
11.16.2 Technogym SpA (Italy) Obesity Treatment Product Offered
11.16.3 Technogym SpA (Italy) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Technogym SpA (Italy) Main Business Overview
11.16.5 Technogym SpA (Italy) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Obesity Treatment Market Size 2018-2029
2.1.2 Obesity Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Obesity Treatment Segment by Type
2.2.1 Surgical & Implant Devices
2.2.2 Medication Therapy
2.2.3 Dietary
2.2.4 Other
2.3 Obesity Treatment Market Size by Type
2.3.1 Obesity Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Obesity Treatment Market Size Market Share by Type (2018-2023)
2.4 Obesity Treatment Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Obesity Treatment Market Size by Application
2.5.1 Obesity Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Obesity Treatment Market Size Market Share by Application (2018-2023)
3 OBESITY TREATMENT MARKET SIZE BY PLAYER
3.1 Obesity Treatment Market Size Market Share by Players
3.1.1 Global Obesity Treatment Revenue by Players (2018-2023)
3.1.2 Global Obesity Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Obesity Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OBESITY TREATMENT BY REGIONS
4.1 Obesity Treatment Market Size by Regions (2018-2023)
4.2 Americas Obesity Treatment Market Size Growth (2018-2023)
4.3 APAC Obesity Treatment Market Size Growth (2018-2023)
4.4 Europe Obesity Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Obesity Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Obesity Treatment Market Size by Country (2018-2023)
5.2 Americas Obesity Treatment Market Size by Type (2018-2023)
5.3 Americas Obesity Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Obesity Treatment Market Size by Region (2018-2023)
6.2 APAC Obesity Treatment Market Size by Type (2018-2023)
6.3 APAC Obesity Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Obesity Treatment by Country (2018-2023)
7.2 Europe Obesity Treatment Market Size by Type (2018-2023)
7.3 Europe Obesity Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Obesity Treatment by Region (2018-2023)
8.2 Middle East & Africa Obesity Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Obesity Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OBESITY TREATMENT MARKET FORECAST
10.1 Global Obesity Treatment Forecast by Regions (2024-2029)
10.1.1 Global Obesity Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Obesity Treatment Forecast
10.1.3 APAC Obesity Treatment Forecast
10.1.4 Europe Obesity Treatment Forecast
10.1.5 Middle East & Africa Obesity Treatment Forecast
10.2 Americas Obesity Treatment Forecast by Country (2024-2029)
10.2.1 United States Obesity Treatment Market Forecast
10.2.2 Canada Obesity Treatment Market Forecast
10.2.3 Mexico Obesity Treatment Market Forecast
10.2.4 Brazil Obesity Treatment Market Forecast
10.3 APAC Obesity Treatment Forecast by Region (2024-2029)
10.3.1 China Obesity Treatment Market Forecast
10.3.2 Japan Obesity Treatment Market Forecast
10.3.3 Korea Obesity Treatment Market Forecast
10.3.4 Southeast Asia Obesity Treatment Market Forecast
10.3.5 India Obesity Treatment Market Forecast
10.3.6 Australia Obesity Treatment Market Forecast
10.4 Europe Obesity Treatment Forecast by Country (2024-2029)
10.4.1 Germany Obesity Treatment Market Forecast
10.4.2 France Obesity Treatment Market Forecast
10.4.3 UK Obesity Treatment Market Forecast
10.4.4 Italy Obesity Treatment Market Forecast
10.4.5 Russia Obesity Treatment Market Forecast
10.5 Middle East & Africa Obesity Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Obesity Treatment Market Forecast
10.5.2 South Africa Obesity Treatment Market Forecast
10.5.3 Israel Obesity Treatment Market Forecast
10.5.4 Turkey Obesity Treatment Market Forecast
10.5.5 GCC Countries Obesity Treatment Market Forecast
10.6 Global Obesity Treatment Forecast by Type (2024-2029)
10.7 Global Obesity Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 NutriSystem, Inc. (U.S.)
11.1.1 NutriSystem, Inc. (U.S.) Company Information
11.1.2 NutriSystem, Inc. (U.S.) Obesity Treatment Product Offered
11.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 NutriSystem, Inc. (U.S.) Main Business Overview
11.1.5 NutriSystem, Inc. (U.S.) Latest Developments
11.2 Kellogg Company (U.S.)
11.2.1 Kellogg Company (U.S.) Company Information
11.2.2 Kellogg Company (U.S.) Obesity Treatment Product Offered
11.2.3 Kellogg Company (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Kellogg Company (U.S.) Main Business Overview
11.2.5 Kellogg Company (U.S.) Latest Developments
11.3 Ethicon, Inc. (U.S.)
11.3.1 Ethicon, Inc. (U.S.) Company Information
11.3.2 Ethicon, Inc. (U.S.) Obesity Treatment Product Offered
11.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Ethicon, Inc. (U.S.) Main Business Overview
11.3.5 Ethicon, Inc. (U.S.) Latest Developments
11.4 Medtronic (U.S.)
11.4.1 Medtronic (U.S.) Company Information
11.4.2 Medtronic (U.S.) Obesity Treatment Product Offered
11.4.3 Medtronic (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Medtronic (U.S.) Main Business Overview
11.4.5 Medtronic (U.S.) Latest Developments
11.5 F. Hoffmann-La Roche (Switzerland)
11.5.1 F. Hoffmann-La Roche (Switzerland) Company Information
11.5.2 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Offered
11.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 F. Hoffmann-La Roche (Switzerland) Main Business Overview
11.5.5 F. Hoffmann-La Roche (Switzerland) Latest Developments
11.6 Atkins Nutritionals, Inc. (U.S.)
11.6.1 Atkins Nutritionals, Inc. (U.S.) Company Information
11.6.2 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product Offered
11.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Atkins Nutritionals, Inc. (U.S.) Main Business Overview
11.6.5 Atkins Nutritionals, Inc. (U.S.) Latest Developments
11.7 Herbalife Ltd. (U.S.)
11.7.1 Herbalife Ltd. (U.S.) Company Information
11.7.2 Herbalife Ltd. (U.S.) Obesity Treatment Product Offered
11.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Herbalife Ltd. (U.S.) Main Business Overview
11.7.5 Herbalife Ltd. (U.S.) Latest Developments
11.8 Covidien plc (U.S.)
11.8.1 Covidien plc (U.S.) Company Information
11.8.2 Covidien plc (U.S.) Obesity Treatment Product Offered
11.8.3 Covidien plc (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Covidien plc (U.S.) Main Business Overview
11.8.5 Covidien plc (U.S.) Latest Developments
11.9 Apollo Endosurgery (U.S.)
11.9.1 Apollo Endosurgery (U.S.) Company Information
11.9.2 Apollo Endosurgery (U.S.) Obesity Treatment Product Offered
11.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Apollo Endosurgery (U.S.) Main Business Overview
11.9.5 Apollo Endosurgery (U.S.) Latest Developments
11.10 Amer Sports (Finland)
11.10.1 Amer Sports (Finland) Company Information
11.10.2 Amer Sports (Finland) Obesity Treatment Product Offered
11.10.3 Amer Sports (Finland) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Amer Sports (Finland) Main Business Overview
11.10.5 Amer Sports (Finland) Latest Developments
11.11 Johnson Health Technology, Ltd. (Taiwan)
11.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Information
11.11.2 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product Offered
11.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Johnson Health Technology, Ltd. (Taiwan) Main Business Overview
11.11.5 Johnson Health Technology, Ltd. (Taiwan) Latest Developments
11.12 Cybex International (U.S.)
11.12.1 Cybex International (U.S.) Company Information
11.12.2 Cybex International (U.S.) Obesity Treatment Product Offered
11.12.3 Cybex International (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Cybex International (U.S.) Main Business Overview
11.12.5 Cybex International (U.S.) Latest Developments
11.13 USGI Medical (U.S.)
11.13.1 USGI Medical (U.S.) Company Information
11.13.2 USGI Medical (U.S.) Obesity Treatment Product Offered
11.13.3 USGI Medical (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 USGI Medical (U.S.) Main Business Overview
11.13.5 USGI Medical (U.S.) Latest Developments
11.14 Olympus Corporation (Japan)
11.14.1 Olympus Corporation (Japan) Company Information
11.14.2 Olympus Corporation (Japan) Obesity Treatment Product Offered
11.14.3 Olympus Corporation (Japan) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Olympus Corporation (Japan) Main Business Overview
11.14.5 Olympus Corporation (Japan) Latest Developments
11.15 Brunswick Corporation (U.S.)
11.15.1 Brunswick Corporation (U.S.) Company Information
11.15.2 Brunswick Corporation (U.S.) Obesity Treatment Product Offered
11.15.3 Brunswick Corporation (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Brunswick Corporation (U.S.) Main Business Overview
11.15.5 Brunswick Corporation (U.S.) Latest Developments
11.16 Technogym SpA (Italy)
11.16.1 Technogym SpA (Italy) Company Information
11.16.2 Technogym SpA (Italy) Obesity Treatment Product Offered
11.16.3 Technogym SpA (Italy) Obesity Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Technogym SpA (Italy) Main Business Overview
11.16.5 Technogym SpA (Italy) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Obesity Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Surgical & Implant Devices
Table 3. Major Players of Medication Therapy
Table 4. Major Players of Dietary
Table 5. Major Players of Other
Table 6. Obesity Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 9. Obesity Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Obesity Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Obesity Treatment Revenue Market Share by Player (2018-2023)
Table 14. Obesity Treatment Key Players Head office and Products Offered
Table 15. Obesity Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Obesity Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Obesity Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Obesity Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Obesity Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Obesity Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Obesity Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Obesity Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Obesity Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Obesity Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Obesity Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Obesity Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Obesity Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Obesity Treatment
Table 47. Key Market Challenges & Risks of Obesity Treatment
Table 48. Key Industry Trends of Obesity Treatment
Table 49. Global Obesity Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Obesity Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Obesity Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Obesity Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. NutriSystem, Inc. (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 54. NutriSystem, Inc. (U.S.) Obesity Treatment Product Offered
Table 55. NutriSystem, Inc. (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. NutriSystem, Inc. (U.S.) Main Business
Table 57. NutriSystem, Inc. (U.S.) Latest Developments
Table 58. Kellogg Company (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 59. Kellogg Company (U.S.) Obesity Treatment Product Offered
Table 60. Kellogg Company (U.S.) Main Business
Table 61. Kellogg Company (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Kellogg Company (U.S.) Latest Developments
Table 63. Ethicon, Inc. (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 64. Ethicon, Inc. (U.S.) Obesity Treatment Product Offered
Table 65. Ethicon, Inc. (U.S.) Main Business
Table 66. Ethicon, Inc. (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Ethicon, Inc. (U.S.) Latest Developments
Table 68. Medtronic (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 69. Medtronic (U.S.) Obesity Treatment Product Offered
Table 70. Medtronic (U.S.) Main Business
Table 71. Medtronic (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Medtronic (U.S.) Latest Developments
Table 73. F. Hoffmann-La Roche (Switzerland) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 74. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Offered
Table 75. F. Hoffmann-La Roche (Switzerland) Main Business
Table 76. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. F. Hoffmann-La Roche (Switzerland) Latest Developments
Table 78. Atkins Nutritionals, Inc. (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 79. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product Offered
Table 80. Atkins Nutritionals, Inc. (U.S.) Main Business
Table 81. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Atkins Nutritionals, Inc. (U.S.) Latest Developments
Table 83. Herbalife Ltd. (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 84. Herbalife Ltd. (U.S.) Obesity Treatment Product Offered
Table 85. Herbalife Ltd. (U.S.) Main Business
Table 86. Herbalife Ltd. (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Herbalife Ltd. (U.S.) Latest Developments
Table 88. Covidien plc (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 89. Covidien plc (U.S.) Obesity Treatment Product Offered
Table 90. Covidien plc (U.S.) Main Business
Table 91. Covidien plc (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Covidien plc (U.S.) Latest Developments
Table 93. Apollo Endosurgery (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 94. Apollo Endosurgery (U.S.) Obesity Treatment Product Offered
Table 95. Apollo Endosurgery (U.S.) Main Business
Table 96. Apollo Endosurgery (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Apollo Endosurgery (U.S.) Latest Developments
Table 98. Amer Sports (Finland) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 99. Amer Sports (Finland) Obesity Treatment Product Offered
Table 100. Amer Sports (Finland) Main Business
Table 101. Amer Sports (Finland) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Amer Sports (Finland) Latest Developments
Table 103. Johnson Health Technology, Ltd. (Taiwan) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 104. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product Offered
Table 105. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Johnson Health Technology, Ltd. (Taiwan) Main Business
Table 107. Johnson Health Technology, Ltd. (Taiwan) Latest Developments
Table 108. Cybex International (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 109. Cybex International (U.S.) Obesity Treatment Product Offered
Table 110. Cybex International (U.S.) Main Business
Table 111. Cybex International (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Cybex International (U.S.) Latest Developments
Table 113. USGI Medical (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 114. USGI Medical (U.S.) Obesity Treatment Product Offered
Table 115. USGI Medical (U.S.) Main Business
Table 116. USGI Medical (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. USGI Medical (U.S.) Latest Developments
Table 118. Olympus Corporation (Japan) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 119. Olympus Corporation (Japan) Obesity Treatment Product Offered
Table 120. Olympus Corporation (Japan) Main Business
Table 121. Olympus Corporation (Japan) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Olympus Corporation (Japan) Latest Developments
Table 123. Brunswick Corporation (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 124. Brunswick Corporation (U.S.) Obesity Treatment Product Offered
Table 125. Brunswick Corporation (U.S.) Main Business
Table 126. Brunswick Corporation (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Brunswick Corporation (U.S.) Latest Developments
Table 128. Technogym SpA (Italy) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 129. Technogym SpA (Italy) Obesity Treatment Product Offered
Table 130. Technogym SpA (Italy) Main Business
Table 131. Technogym SpA (Italy) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Technogym SpA (Italy) Latest Developments
Table 1. Obesity Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Surgical & Implant Devices
Table 3. Major Players of Medication Therapy
Table 4. Major Players of Dietary
Table 5. Major Players of Other
Table 6. Obesity Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 9. Obesity Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Obesity Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Obesity Treatment Revenue Market Share by Player (2018-2023)
Table 14. Obesity Treatment Key Players Head office and Products Offered
Table 15. Obesity Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Obesity Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Obesity Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Obesity Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Obesity Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Obesity Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Obesity Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Obesity Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Obesity Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Obesity Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Obesity Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Obesity Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Obesity Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Obesity Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Obesity Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Obesity Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Obesity Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Obesity Treatment
Table 47. Key Market Challenges & Risks of Obesity Treatment
Table 48. Key Industry Trends of Obesity Treatment
Table 49. Global Obesity Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Obesity Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Obesity Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Obesity Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. NutriSystem, Inc. (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 54. NutriSystem, Inc. (U.S.) Obesity Treatment Product Offered
Table 55. NutriSystem, Inc. (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. NutriSystem, Inc. (U.S.) Main Business
Table 57. NutriSystem, Inc. (U.S.) Latest Developments
Table 58. Kellogg Company (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 59. Kellogg Company (U.S.) Obesity Treatment Product Offered
Table 60. Kellogg Company (U.S.) Main Business
Table 61. Kellogg Company (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Kellogg Company (U.S.) Latest Developments
Table 63. Ethicon, Inc. (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 64. Ethicon, Inc. (U.S.) Obesity Treatment Product Offered
Table 65. Ethicon, Inc. (U.S.) Main Business
Table 66. Ethicon, Inc. (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Ethicon, Inc. (U.S.) Latest Developments
Table 68. Medtronic (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 69. Medtronic (U.S.) Obesity Treatment Product Offered
Table 70. Medtronic (U.S.) Main Business
Table 71. Medtronic (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Medtronic (U.S.) Latest Developments
Table 73. F. Hoffmann-La Roche (Switzerland) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 74. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product Offered
Table 75. F. Hoffmann-La Roche (Switzerland) Main Business
Table 76. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. F. Hoffmann-La Roche (Switzerland) Latest Developments
Table 78. Atkins Nutritionals, Inc. (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 79. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product Offered
Table 80. Atkins Nutritionals, Inc. (U.S.) Main Business
Table 81. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Atkins Nutritionals, Inc. (U.S.) Latest Developments
Table 83. Herbalife Ltd. (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 84. Herbalife Ltd. (U.S.) Obesity Treatment Product Offered
Table 85. Herbalife Ltd. (U.S.) Main Business
Table 86. Herbalife Ltd. (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Herbalife Ltd. (U.S.) Latest Developments
Table 88. Covidien plc (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 89. Covidien plc (U.S.) Obesity Treatment Product Offered
Table 90. Covidien plc (U.S.) Main Business
Table 91. Covidien plc (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Covidien plc (U.S.) Latest Developments
Table 93. Apollo Endosurgery (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 94. Apollo Endosurgery (U.S.) Obesity Treatment Product Offered
Table 95. Apollo Endosurgery (U.S.) Main Business
Table 96. Apollo Endosurgery (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Apollo Endosurgery (U.S.) Latest Developments
Table 98. Amer Sports (Finland) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 99. Amer Sports (Finland) Obesity Treatment Product Offered
Table 100. Amer Sports (Finland) Main Business
Table 101. Amer Sports (Finland) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Amer Sports (Finland) Latest Developments
Table 103. Johnson Health Technology, Ltd. (Taiwan) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 104. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product Offered
Table 105. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Johnson Health Technology, Ltd. (Taiwan) Main Business
Table 107. Johnson Health Technology, Ltd. (Taiwan) Latest Developments
Table 108. Cybex International (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 109. Cybex International (U.S.) Obesity Treatment Product Offered
Table 110. Cybex International (U.S.) Main Business
Table 111. Cybex International (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Cybex International (U.S.) Latest Developments
Table 113. USGI Medical (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 114. USGI Medical (U.S.) Obesity Treatment Product Offered
Table 115. USGI Medical (U.S.) Main Business
Table 116. USGI Medical (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. USGI Medical (U.S.) Latest Developments
Table 118. Olympus Corporation (Japan) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 119. Olympus Corporation (Japan) Obesity Treatment Product Offered
Table 120. Olympus Corporation (Japan) Main Business
Table 121. Olympus Corporation (Japan) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Olympus Corporation (Japan) Latest Developments
Table 123. Brunswick Corporation (U.S.) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 124. Brunswick Corporation (U.S.) Obesity Treatment Product Offered
Table 125. Brunswick Corporation (U.S.) Main Business
Table 126. Brunswick Corporation (U.S.) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Brunswick Corporation (U.S.) Latest Developments
Table 128. Technogym SpA (Italy) Details, Company Type, Obesity Treatment Area Served and Its Competitors
Table 129. Technogym SpA (Italy) Obesity Treatment Product Offered
Table 130. Technogym SpA (Italy) Main Business
Table 131. Technogym SpA (Italy) Obesity Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Technogym SpA (Italy) Latest Developments
LIST OF FIGURES
Figure 1. Obesity Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Obesity Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Obesity Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Obesity Treatment Sales Market Share by Country/Region (2022)
Figure 8. Obesity Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Obesity Treatment Market Size Market Share by Type in 2022
Figure 10. Obesity Treatment in Children
Figure 11. Global Obesity Treatment Market: Children (2018-2023) & ($ Millions)
Figure 12. Obesity Treatment in Adults
Figure 13. Global Obesity Treatment Market: Adults (2018-2023) & ($ Millions)
Figure 14. Global Obesity Treatment Market Size Market Share by Application in 2022
Figure 15. Global Obesity Treatment Revenue Market Share by Player in 2022
Figure 16. Global Obesity Treatment Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Obesity Treatment Market Size 2018-2023 ($ Millions)
Figure 18. APAC Obesity Treatment Market Size 2018-2023 ($ Millions)
Figure 19. Europe Obesity Treatment Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Obesity Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Americas Obesity Treatment Value Market Share by Country in 2022
Figure 22. United States Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Obesity Treatment Market Size Market Share by Region in 2022
Figure 27. APAC Obesity Treatment Market Size Market Share by Type in 2022
Figure 28. APAC Obesity Treatment Market Size Market Share by Application in 2022
Figure 29. China Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Obesity Treatment Market Size Market Share by Country in 2022
Figure 36. Europe Obesity Treatment Market Size Market Share by Type (2018-2023)
Figure 37. Europe Obesity Treatment Market Size Market Share by Application (2018-2023)
Figure 38. Germany Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Obesity Treatment Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Obesity Treatment Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Obesity Treatment Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 52. APAC Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 53. Europe Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 55. United States Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Canada Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 59. China Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Japan Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 61. Korea Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 63. India Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Australia Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 65. Germany Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 66. France Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 67. UK Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 68. Italy Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 69. Russia Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Spain Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Israel Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Global Obesity Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Obesity Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Obesity Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Obesity Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Obesity Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Obesity Treatment Sales Market Share by Country/Region (2022)
Figure 8. Obesity Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Obesity Treatment Market Size Market Share by Type in 2022
Figure 10. Obesity Treatment in Children
Figure 11. Global Obesity Treatment Market: Children (2018-2023) & ($ Millions)
Figure 12. Obesity Treatment in Adults
Figure 13. Global Obesity Treatment Market: Adults (2018-2023) & ($ Millions)
Figure 14. Global Obesity Treatment Market Size Market Share by Application in 2022
Figure 15. Global Obesity Treatment Revenue Market Share by Player in 2022
Figure 16. Global Obesity Treatment Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Obesity Treatment Market Size 2018-2023 ($ Millions)
Figure 18. APAC Obesity Treatment Market Size 2018-2023 ($ Millions)
Figure 19. Europe Obesity Treatment Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Obesity Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Americas Obesity Treatment Value Market Share by Country in 2022
Figure 22. United States Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Obesity Treatment Market Size Market Share by Region in 2022
Figure 27. APAC Obesity Treatment Market Size Market Share by Type in 2022
Figure 28. APAC Obesity Treatment Market Size Market Share by Application in 2022
Figure 29. China Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Obesity Treatment Market Size Market Share by Country in 2022
Figure 36. Europe Obesity Treatment Market Size Market Share by Type (2018-2023)
Figure 37. Europe Obesity Treatment Market Size Market Share by Application (2018-2023)
Figure 38. Germany Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Obesity Treatment Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Obesity Treatment Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Obesity Treatment Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Obesity Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 52. APAC Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 53. Europe Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 55. United States Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Canada Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 59. China Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Japan Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 61. Korea Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 63. India Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Australia Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 65. Germany Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 66. France Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 67. UK Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 68. Italy Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 69. Russia Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Spain Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Israel Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Obesity Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Global Obesity Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Obesity Treatment Market Size Market Share Forecast by Application (2024-2029)
More Publications
Global Wire Loop Snare Market Growth 2026-2032
US$ 3,660.00
June 2026
111 pages
Global Hyaluronic Acid Beads Market Growth 2024-2030
US$ 3,660.00
June 2024
101 pages
Global Steam Sterilizer Market Growth 2025-2031
US$ 3,660.00
December 2024
129 pages
Global Walk-in Centre Services Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
155 pages